Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study

被引：0
|
作者：
Shuai Hao
Rongkun Luo
Wei Li
Ruhan Zhao
Tong Qi
Zichen Wang
Nan Li
Ming Liu
机构：
[1] The Third Hospital of Hebei Medical University,Department of Oncology
[2] Graduate School of Hebei Medical University,Department of Hepatobiliary and Pancreatic Surgery
[3] Third Xiangya Hospital,undefined
[4] Central South University,undefined
[5] Xiangya School of Medicine,undefined
[6] Central South University,undefined
来源：
BMC Gastroenterology | / 23卷
关键词：
Hepatocellular carcinoma (HCC); Nomogram; Overall survival(OS); Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study
    Hao, Shuai
    Luo, Rongkun
    Li, Wei
    Zhao, Ruhan
    Qi, Tong
    Wang, Zichen
    Li, Nan
    Liu, Ming
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [2] LENVATINIB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL-WORLD PRACTICE - MULTICENTER ANALYSIS OF PROGNOSTIC FACTORS
    Hiraoka, Atsushi
    Kumada, Takashi
    Atsukawa, Masanori
    Hirooka, Masashi
    Ishikawa, Toru
    Kunihiko, Tsuji
    Takaguchi, Koichi
    Kariyama, Kazuya
    Itobayashi, Ei
    Tajiri, Kazuto
    Shimada, Noritomo
    Shibata, Hiroshi
    Ochi, Hironori
    Tada, Toshifumi
    Toyoda, Hidenori
    Nouso, Kazuhiro
    Tsutsui, Akemi, Sr.
    Nagano, Takuya
    Itokawa, Norio
    Hayama, Korenobu
    Imai, Michitaka
    Joko, Kouji
    Koizumi, Yohei
    Hiasa, Yoichi
    Michitaka, Kojiro
    Kudo, Masatoshi
    HEPATOLOGY, 2019, 70 : 217A - 218A
  • [3] Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study
    Kurvi Patwala
    David Stephen Prince
    Yael Celermajer
    Waafiqa Alam
    Eldho Paul
    Simone Irene Strasser
    Geoffrey William McCaughan
    Paul Gow
    Siddharth Sood
    Elise Murphy
    Stuart Roberts
    Elliot Freeman
    Elizabeth Stratton
    Scott Anthony Davison
    Miriam Tania Levy
    McCawley Clark-Dickson
    Vi Nguyen
    Sally Bell
    Amanda Nicoll
    Ashley Bloom
    Alice Unah Lee
    Marno Ryan
    Jessica Howell
    Zina Valaydon
    Alexandra Mack
    Ken Liu
    Anouk Dev
    Hepatology International, 2022, 16 : 1170 - 1178
  • [4] Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study
    Welland, Sabrina
    Leyh, Catherine
    Finkelmeier, Fabian
    Jefremow, Andre
    Shmanko, Kateryna
    Gonzalez-Carmona, Maria A.
    Kandulski, Arne
    Jeliazkova, Petia
    Best, Jan
    Fruendt, Thorben W.
    Djanani, Angela
    Pangerl, Maria
    Maieron, Andreas
    Greil, Richard
    Fricke, Christina
    Sookthai, Disorn
    Guenther, Rainer
    Schmiderer, Andreas
    Wege, Henning
    Venerito, Marino
    Ehmer, Ursula
    Mueller, Martina
    Strassburg, Christian P.
    Weinmann, Arndt
    Siebler, Jurgen
    Waidmann, Oliver
    Lange, Christian M.
    Saborowski, Anna
    Vogel, Arndt
    LIVER CANCER, 2022, 11 (03) : 219 - 232
  • [5] Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study
    Persano, Mara
    Rimini, Margherita
    Tada, Toshifumi
    Suda, Goki
    Shimose, Shigeo
    Kudo, Masatoshi
    Cheon, Jaekyung
    Finkelmeier, Fabian
    Lim, Ho Yeong
    Rimassa, Lorenza
    Presa, Jose
    Masi, Gianluca
    Yoo, Changhoon
    Lonardi, Sara
    Tovoli, Francesco
    Kumada, Takashi
    Sakamoto, Naoya
    Iwamoto, Hideki
    Aoki, Tomoko
    Chon, Hong Jae
    Himmelsbach, Vera
    Pressiani, Tiziana
    Kawaguchi, Takumi
    Montes, Margarida
    Vivaldi, Caterina
    Solda, Caterina
    Piscaglia, Fabio
    Hiraoka, Atsushi
    Sho, Takuya
    Niizeki, Takashi
    Nishida, Naoshi
    Steup, Christoph
    Iavarone, Massimo
    Di Costanzo, Giovanni
    Marra, Fabio
    Scartozzi, Mario
    Tamburini, Emiliano
    Cabibbo, Giuseppe
    Foschi, Francesco Giuseppe
    Silletta, Marianna
    Hirooka, Masashi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (09) : 5591 - 5602
  • [6] Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study
    Mara Persano
    Margherita Rimini
    Toshifumi Tada
    Goki Suda
    Shigeo Shimose
    Masatoshi Kudo
    Jaekyung Cheon
    Fabian Finkelmeier
    Ho Yeong Lim
    Lorenza Rimassa
    José Presa
    Gianluca Masi
    Changhoon Yoo
    Sara Lonardi
    Francesco Tovoli
    Takashi Kumada
    Naoya Sakamoto
    Hideki Iwamoto
    Tomoko Aoki
    Hong Jae Chon
    Vera Himmelsbach
    Tiziana Pressiani
    Takumi Kawaguchi
    Margarida Montes
    Caterina Vivaldi
    Caterina Soldà
    Fabio Piscaglia
    Atsushi Hiraoka
    Takuya Sho
    Takashi Niizeki
    Naoshi Nishida
    Christoph Steup
    Massimo Iavarone
    Giovanni Di Costanzo
    Fabio Marra
    Mario Scartozzi
    Emiliano Tamburini
    Giuseppe Cabibbo
    Francesco Giuseppe Foschi
    Marianna Silletta
    Masashi Hirooka
    Kazuya Kariyama
    Joji Tani
    Masanori Atsukawa
    Koichi Takaguchi
    Ei Itobayashi
    Shinya Fukunishi
    Kunihiko Tsuji
    Toru Ishikawa
    Kazuto Tajiri
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5591 - 5602
  • [7] Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis
    Hiraoka, Atsushi
    Kumada, Takashi
    Atsukawa, Masanori
    Hirooka, Masashi
    Tsuji, Kunihiko
    Ishikawa, Toru
    Takaguchi, Koichi
    Kariyama, Kazuya
    Itobayashi, Ei
    Tajiri, Kazuto
    Shimada, Noritomo
    Shibata, Hiroshi
    Ochi, Hironori
    Tada, Toshifumi
    Toyoda, Hidenori
    Nouso, Kazuhiro
    Tsutsui, Akemi
    Nagano, Takuya
    Itokawa, Norio
    Hayama, Korenobu
    Imai, Michitaka
    Joko, Kouji
    Koizumi, Yohei
    Hiasa, Yoichi
    Michitaka, Kojiro
    Kudo, Masatoshi
    CANCER MEDICINE, 2019, 8 (08): : 3719 - 3728
  • [8] Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis
    Hiraoka, Atsushi
    Kumada, Takashi
    Kariyama, Kazuya
    Takaguchi, Koichi
    Atsukawa, Masanori
    Itobayashi, Ei
    Tsuji, Kunihiko
    Tajiri, Kazuto
    Hirooka, Masashi
    Shimada, Noritomo
    Shibata, Hiroshi
    Ishikawa, Toru
    Ochi, Hironori
    Tada, Toshifumi
    Toyoda, Hidenori
    Nouso, Kazuhiro
    Tsutsui, Akemi
    Itokawa, Norio
    Imai, Michitaka
    Joko, Kouji
    Hiasa, Yoichi
    Michitaka, Kojiro
    CANCER MEDICINE, 2019, 8 (01): : 137 - 146
  • [9] Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort study
    Patwala, Kurvi
    Prince, David Stephen
    Celermajer, Yael
    Alam, Waafiqa
    Paul, Eldho
    Strasser, Simone Irene
    McCaughan, Geoffrey William
    Gow, Paul
    Sood, Siddharth
    Murphy, Elise
    Roberts, Stuart
    Freeman, Elliot
    Stratton, Elizabeth
    Davison, Scott Anthony
    Levy, Miriam Tania
    Clark-Dickson, Mccawley
    Vi Nguyen
    Bell, Sally
    Nicoll, Amanda
    Bloom, Ashley
    Lee, Alice Unah
    Ryan, Marno
    Howell, Jessica
    Valaydon, Zina
    Mack, Alexandra
    Liu, Ken
    Dev, Anouk
    HEPATOLOGY INTERNATIONAL, 2022, 16 (05) : 1170 - 1178
  • [10] Real-world role of performance status in surgical resection for hepatocellular carcinoma: A multicenter study
    Wu, Han
    Xing, Hao
    Liang, Lei
    Huang, Bin
    Li, Chao
    Lau, Wan Yee
    Zhou, Ya-Hao
    Gu, Wei-Min
    Wang, Hong
    Chen, Ting-Hao
    Zhang, Yao-Ming
    Zeng, Yong-Yi
    Pawlik, Timothy M.
    Wang, Ming-Da
    Wu, Meng-Chao
    Shen, Feng
    Yang, Tian
    EJSO, 2019, 45 (12): : 2360 - 2368
12345